4//SEC Filing
Johnson Paul D 4
Accession 0001209191-21-062815
CIK 0001804591other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 7:07 PM ET
Size
20.5 KB
Accession
0001209191-21-062815
Insider Transaction Report
Form 4
Johnson Paul D
VP, General Manager-Consumer
Transactions
- Award
Class A Common Stock
2021-11-01+746,213→ 746,213 total - Award
Stock Option (Right to Buy)
2021-11-01+293,448→ 293,448 totalExercise: $0.35Exp: 2029-04-02→ Class A Common Stock (293,448 underlying) - Award
Stock Option (Right to Buy)
2021-11-01+656,540→ 656,540 totalExercise: $0.30Exp: 2026-05-08→ Class A Common Stock (656,540 underlying) - Award
Stock Option (Right to Buy)
2021-11-01+264,506→ 264,506 totalExercise: $11.72Exp: 2031-10-31→ Class A Common Stock (264,506 underlying) - Award
Class A Common Stock
2021-11-01+352,004→ 1,098,217 total - Award
Stock Option (Right to Buy)
2021-11-01+161,699→ 161,699 totalExercise: $0.34Exp: 2027-09-02→ Class A Common Stock (161,699 underlying) - Award
Stock Option (Right to Buy)
2021-11-01+983,582→ 983,582 totalExercise: $0.96Exp: 2030-09-22→ Class A Common Stock (983,582 underlying)
Footnotes (7)
- [F1]Received as the share portion of the merger consideration payable in connection with the acquisition of Lemonaid Health, Inc., a Delaware corporation ("Lemonaid Health"), by 23andMe Holding Co. (the "Company") (such acquisition, the "Merger"), in exchange for 526,715 shares of common stock and 23,591 shares of preferred stock of Lemonaid Health. 535,669 of such shares of the Company's Class A common stock are subject to that certain Relinquishment Agreement (the "Relinquishment Agreement"), by and between the Company and the reporting person, dated as of November 1, 2021. Pursuant to the Relinquishment Agreement, 535,669 of such shares of the Company's Class A common stock vest over a four-year period, with 1/16 of such shares vesting every three months, beginning on February 1, 2022. The vesting of such shares is subject to certain terms and conditions, including, without limitation, the reporting person's continued service for the Company.
- [F2]Grant of restricted stock units (the "RSUs") under the Company's 2021 Incentive Equity Plan (the "Plan"). The RSUs vest over a four-year period, with an initial 25% vesting on November 1, 2022, and the remainder vesting on a quarterly basis thereafter. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
- [F3]Received in the Merger in exchange for an option to purchase 363,214 shares of common stock of Lemonaid Health. Such stock options vest over a four-year period, with 1/16 of such options vesting every three months, beginning on February 1, 2022.
- [F4]Received in the Merger in exchange for an option to purchase 89,456 shares of common stock of Lemonaid Health. Such stock options vest over a four-year period, with 1/16 of such options vesting every three months, beginning on February 1, 2022.
- [F5]Received in the Merger in exchange for an option to purchase 162,343 shares of common stock of Lemonaid Health. Such stock options vest over a four-year period, with 1/16 of such options vesting every three months, beginning on February 1, 2022.
- [F6]Received in the Merger in exchange for an option to purchase 544,142 shares of common stock of Lemonaid Health. Such stock options vest over a four-year period, with 1/16 of such options vesting every three months, beginning on February 1, 2022.
- [F7]Grant of stock options under the Plan. The stock options vest over a four-year period, with an initial 25% vesting on November 1, 2022, and the remainder vesting on a quarterly basis thereafter. The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations.
Documents
Issuer
23andMe Holding Co.
CIK 0001804591
Entity typeother
Related Parties
1- filerCIK 0001891761
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 7:07 PM ET
- Size
- 20.5 KB